BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14620505)

  • 1. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity.
    Jevprasesphant R; Penny J; Attwood D; McKeown NB; D'Emanuele A
    Pharm Res; 2003 Oct; 20(10):1543-50. PubMed ID: 14620505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of surface modification on the cytotoxicity of PAMAM dendrimers.
    Jevprasesphant R; Penny J; Jalal R; Attwood D; McKeown NB; D'Emanuele A
    Int J Pharm; 2003 Feb; 252(1-2):263-6. PubMed ID: 12550802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling.
    Kitchens KM; Kolhatkar RB; Swaan PW; Eddington ND; Ghandehari H
    Pharm Res; 2006 Dec; 23(12):2818-26. PubMed ID: 17094034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.
    El-Sayed M; Ginski M; Rhodes C; Ghandehari H
    J Control Release; 2002 Jun; 81(3):355-65. PubMed ID: 12044574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
    Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
    Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
    Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Morphology and Transport of PAMAM Dendrimers Across Isolated Rat Intestinal Tissue.
    Hubbard D; Bond T; Ghandehari H
    Macromol Biosci; 2015 Dec; 15(12):1735-43. PubMed ID: 26332343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.
    Jevprasesphant R; Penny J; Attwood D; D'Emanuele A
    J Control Release; 2004 Jun; 97(2):259-67. PubMed ID: 15196753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.
    D'Emanuele A; Jevprasesphant R; Penny J; Attwood D
    J Control Release; 2004 Mar; 95(3):447-53. PubMed ID: 15023456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates.
    Najlah M; Freeman S; Khoder M; Attwood D; D'Emanuele A
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28976921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular Ca2+ release mediates cationic but not anionic poly(amidoamine) (PAMAM) dendrimer-induced tight junction modulation.
    Avaritt BR; Swaan PW
    Pharm Res; 2014 Sep; 31(9):2429-38. PubMed ID: 24648136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization.
    Saovapakhiran A; D'Emanuele A; Attwood D; Penny J
    Bioconjug Chem; 2009 Apr; 20(4):693-701. PubMed ID: 19271737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
    Kitchens KM; El-Sayed ME; Ghandehari H
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Permeation of Acamprosate Is Predominantly Caused by Paracellular Diffusion across Caco-2 Cell Monolayers: A Paracellular Modeling Approach.
    Antonescu IE; Rasmussen KF; Neuhoff S; Fretté X; Karlgren M; Bergström CAS; Nielsen CU; Steffansen B
    Mol Pharm; 2019 Nov; 16(11):4636-4650. PubMed ID: 31560549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
    Lin YL; Khanafer K; El-Sayed ME
    Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
    Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
    Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.
    Hubbard D; Enda M; Bond T; Moghaddam SP; Conarton J; Scaife C; Volckmann E; Ghandehari H
    Mol Pharm; 2015 Nov; 12(11):4099-107. PubMed ID: 26414679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transepithelial transport of PAMAM dendrimers across isolated rat jejunal mucosae in ussing chambers.
    Hubbard D; Ghandehari H; Brayden DJ
    Biomacromolecules; 2014 Aug; 15(8):2889-95. PubMed ID: 24992090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.
    Sweet DM; Kolhatkar RB; Ray A; Swaan P; Ghandehari H
    J Control Release; 2009 Aug; 138(1):78-85. PubMed ID: 19393702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.